319 related articles for article (PubMed ID: 35757736)
1. Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside.
Shamshiripour P; Hajiahmadi F; Lotfi S; Esmaeili NR; Zare A; Akbarpour M; Ahmadvand D
Front Immunol; 2022; 13():859633. PubMed ID: 35757736
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?
Pellerino A; Bruno F; Soffietti R; Rudà R
Curr Oncol Rep; 2023 Jul; 25(7):777-785. PubMed ID: 37071295
[TBL] [Abstract][Full Text] [Related]
3. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
Wong ML; Prawira A; Kaye AH; Hovens CM
J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
[TBL] [Abstract][Full Text] [Related]
4. Novel anti-angiogenic therapies for malignant gliomas.
Norden AD; Drappatz J; Wen PY
Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
[TBL] [Abstract][Full Text] [Related]
5. Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms.
Miletic H; Niclou SP; Johansson M; Bjerkvig R
Expert Opin Ther Targets; 2009 Apr; 13(4):455-68. PubMed ID: 19335067
[TBL] [Abstract][Full Text] [Related]
6. Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment.
Hatipoglu G; Hock SW; Weiss R; Fan Z; Sehm T; Ghoochani A; Buchfelder M; Savaskan NE; Eyüpoglu IY
Cancer Sci; 2015 Feb; 106(2):160-70. PubMed ID: 25458015
[TBL] [Abstract][Full Text] [Related]
7. [Benefits and Prospects of VEGF-targeted Anti-angiogenic Therapy and Immunotherapy for High-grade Glioma].
Ishikawa E; Miyazaki T
No Shinkei Geka; 2021 May; 49(3):597-607. PubMed ID: 34092565
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in malignant glioma--a target for antitumor therapy?
Tuettenberg J; Friedel C; Vajkoczy P
Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996
[TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic therapy in glioma.
Butowski N
Clin Transl Oncol; 2011 May; 13(5):294-300. PubMed ID: 21596656
[TBL] [Abstract][Full Text] [Related]
10. Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma.
Ahir BK; Engelhard HH; Lakka SS
Mol Neurobiol; 2020 May; 57(5):2461-2478. PubMed ID: 32152825
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic inhibition in high-grade gliomas: past, present and future.
Jo J; Schiff D; Purow B
Expert Rev Neurother; 2012 Jun; 12(6):733-47. PubMed ID: 22650175
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic therapy in malignant glioma: promise and challenge.
Sathornsumetee S; Rich JN
Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
[TBL] [Abstract][Full Text] [Related]
13. Advances in Anti-Cancer Drug Development: Metformin as Anti-Angiogenic Supplemental Treatment for Glioblastoma.
Shah S; Mansour HM; Aguilar TM; Lucke-Wold B
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891882
[TBL] [Abstract][Full Text] [Related]
14. [Angiogenesis and anti-angiogenic strategies for glioblastoma].
de Boüard S; Guillamo JS
Bull Cancer; 2005 Apr; 92(4):360-72. PubMed ID: 15888393
[TBL] [Abstract][Full Text] [Related]
15. Glioma angiogenesis: Towards novel RNA therapeutics.
Würdinger T; Tannous BA
Cell Adh Migr; 2009; 3(2):230-5. PubMed ID: 19262177
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic and macrophage-based therapeutic strategies for glioma immunotherapy.
Ishikawa E; Miyazaki T; Takano S; Akutsu H
Brain Tumor Pathol; 2021 Jul; 38(3):149-155. PubMed ID: 33977360
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas.
Argyriou AA; Giannopoulou E; Kalofonos HP
Oncology; 2009; 77(1):1-11. PubMed ID: 19439998
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic approaches to malignant gliomas.
Soffietti R; Trevisan E; Bertero L; Bosa C; Ruda R
Curr Cancer Drug Targets; 2012 Mar; 12(3):279-88. PubMed ID: 22229250
[TBL] [Abstract][Full Text] [Related]
19. Multiprong control of glioblastoma multiforme invasiveness: blockade of pro-inflammatory signaling, anti-angiogenesis, and homeostasis restoration.
Bazan NG; Reid MM; Flores VAC; Gallo JE; Lewis W; Belayev L
Cancer Metastasis Rev; 2021 Sep; 40(3):643-647. PubMed ID: 34519960
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis factors in gliomas: a new key to tumour therapy?
Mentlein R; Held-Feindt J
Naturwissenschaften; 2003 Sep; 90(9):385-94. PubMed ID: 14504780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
